Literature DB >> 23725535

Dual-functional abeo-taxane derivatives destabilizing microtubule equilibrium and inhibiting NF-κB activation.

Yu Zhao1, Jia Su, Masuo Goto, Susan L Morris-Natschke, Yan Li, Qin-Shi Zhao, Zhu-Jun Yao, Kuo-Hsiung Lee.   

Abstract

Taxchinin A, with a 11(15→1)-abeo-taxane skeleton, is a major, but inactive taxoid contained in leaves of Taxus chinensis . In our design of dual-functional antitumor abeo-taxane derivatives, two fragments from antitumor agents with different molecular targets (the N-acyl-3'-phenylisoserine side chain from the antimitotic agent paclitaxel and an α,β-unsaturated carbonyl system from NF-κB inhibitors) were incorporated into the scaffold of taxchinin A. The resulting compounds displayed broad inhibitory effects against proliferation of tumor cell lines, with notable selectivity toward colon cancer, melanoma, and renal cancer, when evaluated in the NCI-60 human tumor cell line screening panel. On the basis of the NCI-60 assay data, structure-activity relationship (SAR) correlations were elucidated. Mechanistic studies indicated that this new compound type can both destabilize microtubules and inhibit NF-κB activation, thereby inducing tumor cell apoptosis. This first report of the dual-functional taxoid-core compounds thus provides new opportunities for future drug development based on natural axoid scaffolds.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725535      PMCID: PMC3755589          DOI: 10.1021/jm400479p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

Review 1.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.

Authors:  Itsuro Sohma; Yoshiyuki Fujiwara; Yurika Sugita; Akiko Yoshioka; Mitsuhiro Shirakawa; Jeong-Ho Moon; Shuji Takiguchi; Hiroshi Miyata; Makoto Yamasaki; Masaki Mori; Yuichiro Doki
Journal:  Cancer Genomics Proteomics       Date:  2011 Jan-Feb       Impact factor: 4.069

3.  Synthesis and biological activity of A-nor-paclitaxel analogues.

Authors:  M D Chordia; D G Kingston; E Hamel; C M Lin; B H Long; C A Fairchild; K A Johnston; W C Rose
Journal:  Bioorg Med Chem       Date:  1997-05       Impact factor: 3.641

Review 4.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

5.  Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.

Authors:  Z W Gao; D L Zhang; C B Guo
Journal:  Curr Cancer Drug Targets       Date:  2010-11       Impact factor: 3.428

Review 6.  What made sesquiterpene lactones reach cancer clinical trials?

Authors:  Akram Ghantous; Hala Gali-Muhtasib; Heikki Vuorela; Najat A Saliba; Nadine Darwiche
Journal:  Drug Discov Today       Date:  2010-06-09       Impact factor: 7.851

Review 7.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

8.  Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.

Authors:  Srinivas Ganta; Mansoor Amiji
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

9.  NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells.

Authors:  Mohamed Bentires-Alj; Veronique Barbu; Marianne Fillet; Alain Chariot; Biserka Relic; Nathalie Jacobs; Jacques Gielen; Marie-Paule Merville; Vincent Bours
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

10.  Characterization of an abeo-taxane: brevifoliol and derivatives.

Authors:  Steve Tremblay; Chantal Soucy; Neil Towers; Philip J Gunning; Livain Breau
Journal:  J Nat Prod       Date:  2004-05       Impact factor: 4.050

View more
  1 in total

1.  A One-Pot Three-Component Synthesis and Investigation of the In Vitro Mechanistic Anticancer Activity of Highly Functionalized Spirooxindole-Pyrrolidine Heterocyclic Hybrids.

Authors:  Raju Suresh Kumar; Dhaifallah M Al-Thamili; Abdulrahman I Almansour; Natarajan Arumugam; Faruq Mohammad
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.